UBS maintains Willis Towers Watson at Buy, lowers price target to $395 from $398

UBS kept its Buy rating on Willis Towers Watson but reduced its price target to $395 from $398, representing a 0.8% decrease. The new target suggests a 21.3% upside from the stock's recent close of $325.51. Recent analyst price targets for the company range from $310 to $371.

Original reporting
Published Nov 2, 2026, 10:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains Willis Towers Watson at Buy, lowers price target to $395 from $398 — source image
Decision brief

The 30-second read

$WTWBearishLow
01

Why it matters

The target reduction may trigger short-term selling but is unlikely to cause a major trend shift.

02

Market read

A small analyst target adjustment with limited trading impact.

03

What to watch

Recent contract wins and stable earnings could offset the analyst's slight downgrade.

Relevance 5/10Novelty 4/10Timing: today

Background

UBS maintains a Buy rating but adjusts its price target slightly lower, reflecting a modest reassessment of valuation.

Company-level read

Ticker impact

$WTWBearishMedium confidence
Context

UBS lowered its price target on Willis Towers Watson to $395, a new analyst action.

Expected impact

likely pressure as the market prices in the reduced target

Evidence & confidence

Analyst target cuts often lead to short-term sell pressure, especially when the change is modest.

Market effects

Minimal impact on the broader professional services sector.

Limited to U.S. markets where WTW trades.

Low global relevance.

Counterpoint

The target cut may be overly cautious; the stock could hold steady if fundamentals remain strong.

Key entities

  • Willis Towers Watson

    Global advisory, brokering and solutions company.

  • UBS

    Investment bank providing research and ratings.

Related articles

$WTWMed

Willis Re wraps up BMS Re US acquisition

Willis Re completed its acquisition of BMS Re US, expanding its US reinsurance operations and adding capabilities in complex property and casualty risks. The deal includes BMS Intermediaries and BMS Capital Advisory, and was announced in August 2026. Financial terms were not disclosed. Willis Re aims to grow its platform and enhance client value with the acquisition.

$WTWMed

Mizuho raises Willis Towers Watson stock price target on valuation

Mizuho raised its price target on Willis Towers Watson (WTW) to $370 from $349, maintaining an Outperform rating. The stock trades at $324.42, suggesting 14% upside. Mizuho lowered earnings estimates but kept them above consensus. WTW reported Q3 2026 organic growth of 4%, meeting expectations, and exceeded Wall Street's earnings and revenue forecasts. Goldman Sachs and Raymond James also maintained positive ratings with higher price targets.

$WTWHighAI 9/10

What Willis Towers Watson Public (WTW) Said on Its Q3 Earnings Call

Willis Towers Watson (WTW) reported Q3 earnings, with Risk & Broking revenue up 5% organically, driven by North America and international growth. Insurance Consulting and Technology grew 2%, with technology demand strong but consulting revenue down. WTW maintained its outlook for mid-single-digit organic growth and margin expansion. The company is investing in AI initiatives under its Propel plan, expecting $350 million in net run-rate savings by 2028.